Citation Impact
Citing Papers
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
2010 Standout
miR-15 and miR-16 induce apoptosis by targeting BCL2
2005 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Treatment of kidney cancer
2009 StandoutNobel
Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer
2006
Acute Biological Effects of Simulating the Whole-Body Radiation Dose Distribution from a Solar Particle Event Using a Porcine Model
2011 StandoutNobel
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
2006 Standout
A phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapy
2008
EGFR Antagonists in Cancer Treatment
2008 Standout
Therapeutic potential of antisense Bcl‐2 as a chemosensitizer for cancer therapy
2004
Mechanisms, regulation and functions of the unfolded protein response
2020 Standout
pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2
2007 StandoutNobel
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
2016 Standout
Renal Cell Carcinoma Guideline
2007
Tumor necrosis factor, cancer and anticancer therapy
2004
CIP2A is a target of bortezomib in human triple negative breast cancer cells
2012
Cancer drug resistance: an evolving paradigm
2013 Standout
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
The resurgence of platinum-based cancer chemotherapy
2007 Standout
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Proteasome inhibitors as therapeutics
2005
A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma
1996 Standout
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Colorectal cancer
2013 Standout
New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin
2008 Standout
Variants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancer
2005
Molecular mechanisms of cisplatin resistance
2011 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Protein phosphatase type 2A, PP2A, is involved in degradation of gp130
2005
Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation
1994
Apoptosis in cancer: from pathogenesis to treatment
2011 Standout
Death receptors in chemotherapy and cancer
2004
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF-κB-dependent mechanism
2004
The chemoradiation paradigm in head and neck cancer
2007
Novel approaches in the therapy of metastatic renal cell carcinoma
2005
Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium
2004 StandoutNature
The VHL/HIF axis in clear cell renal carcinoma
2012 StandoutNobel
Can NF-κB be a target for novel and efficient anti-cancer agents?
2006
Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma
2004
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines
2009
Novel treatment strategies in clear-cell metastatic renal cell carcinoma
2005
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Revealing the world of RNA interference
2004 StandoutNatureNobel
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
Rejuvenation of aged progenitor cells by exposure to a young systemic environment
2005 StandoutNature
DENDRITIC CELL VACCINATION IN PATIENTS WITH MALIGNANT GLIOMAS
2006
Satraplatin in Hormone-Refractory Prostate Cancer and Other Tumour Types
2007
Oxidative stress and neurodegeneration: where are we now?
2006 Standout
Cancer-related inflammation
2008 StandoutNature
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
Satraplatin: an orally available platinum analog for the treatment of cancer
2006
Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma
2006
The role of IL-6 and STAT3 in inflammation and cancer
2005 Standout
Tumor Angiogenesis
2008 Standout
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
2011
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development
2021 StandoutNobel
Induction of Broad CD4+and CD8+T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5
2008 StandoutNobel
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
The Granulocyte Colony-Stimulating Factor Receptor Is Required for the Mobilization of Murine Hematopoietic Progenitors Into Peripheral Blood by Cyclophosphamide or Interleukin-8 But Not Flt-3 Ligand
1997
Molecular Dynamics Simulation Study of a Polysulfone-Based Anion Exchange Membrane in Comparison with the Proton Exchange Membrane
2014
Induction Chemotherapy Followed by Chemoradiotherapy Compared With Chemoradiotherapy Alone for Regionally Advanced Unresectable Stage III Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B
2007
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
A Novel Viral System for Generating Antigen-Specific T Cells
2005
The proteasome: a novel target for anticancer therapy
2006
A Phase II Trial of Gefitinib (Iressa, ZD1839) in Stage IV and Recurrent Renal Cell Carcinoma
2004
Current Status and Future Prospects for Satraplatin, an Oral Platinum Analogue
2008
Molecular-Scale Electronics: From Concept to Function
2016 Standout
Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle
2001
Anion-exchange membranes in electrochemical energy systems
2014 Standout
Combination therapy in combating cancer
2017 Standout
Bortezomib: Proteasome Inhibition as an Effective Anticancer Therapy
2006
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
The von Hippel-Lindau Tumor Suppressor Protein and Clear Cell Renal Carcinoma
2007 StandoutNobel
Molecular mechanisms of resistance of leukemia to imatinib mesylate
2003
Transport Through Self-Assembled Monolayer Molecular Junctions: Role of In-Plane Dephasing
2014
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
RENAL CELL CARCINOMA 2005: NEW FRONTIERS IN STAGING, PROGNOSTICATION AND TARGETED MOLECULAR THERAPY
2005
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
Antitumor Efficacy of Oblimersen Bcl-2 Antisense Oligonucleotide Alone and in Combination with Vinorelbine in Xenograft Models of Human Non–Small Cell Lung Cancer
2004
Plasma elevation of stromal cell–derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells
2001 StandoutNobel
CNS Metastases in Breast Cancer
2004
Works of Christopher George being referenced
Peripheral Blood Stem Cell Mobilization by Chemotherapy With and Without Recombinant Human Granulocyte Colony-Stimulating Factor
1992
A Phase I Trial of the Oral Platinum Analogue JM216 with Concomitant Radiotherapy in Advanced Malignancies of the Chest
2001
A phase II trial of weekly intravenous gemcitabine and cisplatin with continuous infusion fluorouracil in patients with metastatic renal cell carcinoma
2002
A pilot trial of G3139, a bcl-2 antisense oligonucleotide,and paclitaxel in patients with chemorefractory small-cell lung cancer
2002
A Phase I Study of Pemetrexed, Carboplatin, and Concurrent Radiotherapy in Patients with Locally Advanced or Metastatic Non–Small Cell Lung or Esophageal Cancer
2007
A phase I dose-escalating study of combination pemetrexed-based chemotherapy and concomitant radiotherapy for locally advanced or metastatic non-small cell lung or esophageal cancer
2005
Diagnostic Accuracy of Nodal Enhancement Pattern of Rectal Cancer at MRI Enhanced With Ultrasmall Superparamagnetic Iron Oxide: Findings in Pathologically Matched Mesorectal Lymph Nodes
2010
Prognostic Factors for Survival With Gemcitabine Plus 5-fluorouracil Based Regimens for Metastatic Renal Cancer
2003
Charge Transport through Polyene Self-Assembled Monolayers from Multiscale Computer Simulations
2008
Phase II Trial of PS-341 in Patients With Renal Cell Cancer: A University of Chicago Phase II Consortium Study
2003
Disparate functions of immature and mature human myeloid dendritic cells: implications for dendritic cell-based vaccines
2003